Epacadostat plus pembrolizumab combination shows promise in advanced solid tumours
Headline results from the open-label phase I/II ECHO-202/KEYNOTE-037 trial assessing [...]
Headline results from the open-label phase I/II ECHO-202/KEYNOTE-037 trial assessing [...]
Immunotherapy has revolutionised the treatment of renal cell carcinoma (RCC). [...]
The following video is an interview between PracticeUpdate and Dr Bradley [...]
Drugs that target a protein called indoleamine 2,3-dioxygenase (or IDO [...]
The results from a phase I/II clinical trial of epacadostat [...]